Dynavax Technologies

2 open jobs

Dynavax is a commercial-stage biopharmaceutical company developing and commercializing novel vaccines to help protect against infectious diseases. The company's proprietary CpG 1018 adjuvant powers its vaccine portfolio, including HEPLISAV-B®, approved for hepatitis B prevention in adults, and is being used in development of COVID-19, plague, shingles, and Tdap vaccines.